These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20883200)

  • 1. On the contribution of molecular topology to drug design and discovery.
    Gálvez J; García-Doménech R
    Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latest advances in molecular topology applications for drug discovery.
    Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
    Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular topology as a novel approach for drug discovery.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to molecular topology: basic concepts and application to drug design.
    Gálvez J; Gálvez-Llompart M; García-Domenech R
    Curr Comput Aided Drug Des; 2012 Sep; 8(3):196-223. PubMed ID: 22734705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Editorial: The Expanding Landscape of Graph Theoretic Molecular Descriptors: Development, Gradual Diversification of Descriptor Space, and Applications in QSAR/ QMSA and New Drug Discovery.
    Basak SC
    Curr Comput Aided Drug Des; 2017; 13(3):172-176. PubMed ID: 29517467
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
    Wang T; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What place does molecular topology have in today's drug discovery?
    Zanni R; Galvez-Llompart M; Garcia-Domenech R; Galvez J
    Expert Opin Drug Discov; 2020 Oct; 15(10):1133-1144. PubMed ID: 32496823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of computer-aided drug design in modern drug discovery.
    Macalino SJ; Gosu V; Hong S; Choi S
    Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated drug development approach applying topological descriptors.
    Talevi A; Bellera CL; Di Ianni M; Duchowicz PR; Bruno-Blanch LE; Castro EA
    Curr Comput Aided Drug Des; 2012 Sep; 8(3):172-81. PubMed ID: 22734704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipophilicity in drug design: an overview of lipophilicity descriptors in 3D-QSAR studies.
    Ginex T; Vazquez J; Gilbert E; Herrero E; Luque FJ
    Future Med Chem; 2019 May; 11(10):1177-1193. PubMed ID: 30799643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of
    Haider M; Chauhan A; Tariq S; Pathak DP; Siddiqui N; Ali S; Pottoo FH; Ali R
    Curr Top Med Chem; 2021; 21(11):995-1011. PubMed ID: 34061002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistamines.
    Galvez J; Galvez-Llompart M; Zanni R; Garcia-Domenech R
    Expert Opin Drug Discov; 2013 Mar; 8(3):305-17. PubMed ID: 23289365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent In Silico Resources for Drug Design and Discovery.
    Veljkovic N
    Curr Med Chem; 2019; 26(21):3836-3837. PubMed ID: 31584358
    [No Abstract]   [Full Text] [Related]  

  • 15. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
    Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
    Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of molecular topology for ulcerative colitis drug discovery.
    Bellera CL; Di Ianni ME; Talevi A
    Expert Opin Drug Discov; 2018 Jan; 13(1):89-101. PubMed ID: 29088918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Descriptor Spaces for QSAR: Delving into the History of the Expanding Frontier.
    Basak SC; Mishra RK
    Curr Comput Aided Drug Des; 2017; 13(1):4-7. PubMed ID: 28222673
    [No Abstract]   [Full Text] [Related]  

  • 18. Ligand-based computer-aided discovery of tyrosinase inhibitors. Applications of the TOMOCOMD-CARDD method to the elucidation of new compounds.
    Marrero-Ponce Y; Casañola-Martín GM; Khan MT; Torrens F; Rescigno A; Abad C
    Curr Pharm Des; 2010; 16(24):2601-24. PubMed ID: 20642427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QSAR studies in the discovery of novel type-II diabetic therapies.
    Abuhammad A; Taha MO
    Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patents of bio-active compounds based on computer-aided drug discovery techniques.
    Prado-Prado F; Garcia-Mera X; Rodriguez-Borges JE; Concu R; Perez-Montoto LG; Gonzalez-Diaz H; Duardo-Sanchez A
    Front Biosci (Elite Ed); 2013 Jan; 5(2):399-407. PubMed ID: 23276997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.